We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
-16.69%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$305M
AUM Growth
-$42.5M
Cap. Flow
+$22.1M
Cap. Flow %
7.26%
Top 10 Hldgs %
26.93%
Holding
118
New
12
Increased
35
Reduced
42
Closed
26

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$21.2M
2
CPK icon
Chesapeake Utilities
CPK
+$7.59M
3
MMSI icon
Merit Medical Systems
MMSI
+$6.36M
4
BCPC
Balchem Corp
BCPC
+$5.28M
5
RBC icon
RBC Bearings
RBC
+$4.14M

Top Sells

Rank Stock Value
1
CHRD icon
Chord Energy
CHRD
+$5.21M
2
AERI
Aerie Pharmaceuticals
AERI
+$4.71M
3
OLLI icon
Ollie's Bargain Outlet
OLLI
+$3.4M
4
CDNA icon
CareDx
CDNA
+$3.39M
5
EGHT icon
8x8 Inc
EGHT
+$2.43M

Sector Composition

Rank Sector Weight
1 Financials 15.63%
2 Industrials 13.45%
3 Healthcare 13.09%
4 Technology 10.85%
5 Consumer Discretionary 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYNB
101
Kyntra Bio
KYNB
$29.4M
– –
-1,353
Closed -$2.06M
HEI.A icon
102
HEICO Corp Class A
HEI.A
$37.2B
– –
-3,046
Closed -$230K
HXL icon
103
Hexcel
HXL
$7.82B
– –
-3,259
Closed -$219K
MDGL icon
104
Madrigal Pharmaceuticals
MDGL
$11.8B
– –
-10,467
Closed -$2.24M
NBIX icon
105
Neurocrine Biosciences
NBIX
$16.6B
– –
-1,725
Closed -$212K
NEO icon
106
NeoGenomics
NEO
$2.13B
– –
-155,974
Closed -$2.39M
OLLI icon
107
Ollie's Bargain Outlet
OLLI
$4.94B
– –
-35,351
Closed -$3.4M
PFE icon
108
Pfizer
PFE
$153B
– –
-4,897
Closed -$205K
TGT icon
109
Target
TGT
$68B
– –
-2,533
Closed -$223K
TRU icon
110
TransUnion
TRU
$15.3B
– –
-3,255
Closed -$240K
URGN icon
111
UroGen Pharma
URGN
$2.29B
– –
-18,200
Closed -$860K
WAL icon
112
Western Alliance Bancorporation
WAL
$8.87B
– –
-3,674
Closed -$209K
WST icon
113
West Pharmaceutical
WST
$24.9B
– –
-1,817
Closed -$224K
XNCR icon
114
Xencor
XNCR
$1.55B
– –
-37,598
Closed -$1.47M
SPPI
115
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-70,935
Closed -$1.19M
AERI
116
DELISTED
Aerie Pharmaceuticals
AERI
– –
-76,537
Closed -$4.71M
NTRI
117
DELISTED
NutriSystem, Inc.
NTRI
– –
-64,115
Closed -$2.38M
SIVB
118
DELISTED
SVB Financial Group
SIVB
– –
-905
Closed -$281K
1 2 3 4
5

Similar funds

CAM
Cander Asset Management New York $557M AUM
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return
CFP
Curran Financial Partners Daniel Island, South Carolina $559M AUM 13.69% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return
DIM
Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $560M AUM 62.9% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return

Moody Aldrich Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Moody Aldrich Partners held 118 positions worth $305M, down 12% from $347M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Moody Aldrich Partners deployed $22.1M of net new capital in Q4 2018, opening 12 new positions and adding to 35 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 142,117 shares worth $19M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Welbilt, Inc., an estimated $1.86M trimmed.

  • Moody Aldrich Partners's largest Q4 2018 buy was iShares Russell 2000 ETF: 142,117 shares worth $19M.
  • Moody Aldrich Partners added most to Euronet Worldwide in Q4 2018, an estimated $3.93M increase.
  • Moody Aldrich Partners's biggest Q4 2018 reduction was Welbilt, Inc., cutting an estimated $1.86M.
  • Moody Aldrich Partners fully exited Chord Energy in Q4 2018, selling an estimated $5.21M.
  • Moody Aldrich Partners's ten largest holdings make up 27% of its $305M portfolio in Q4 2018.
  • Moody Aldrich Partners opened 12 new positions and closed 26 in Q4 2018.
  • Moody Aldrich Partners's portfolio value fell 12% quarter-over-quarter to $305M.

Based on Moody Aldrich Partners's 13F filing for Q4 2018, filed 12 Feb 2019.